DEMCON MACAWI RESPIRATORY SYSTEMS BV

Their core work

DEMCON Macawi Respiratory Systems is a Dutch medical device company specializing in the design and manufacture of respiratory and ventilation equipment. As part of the DEMCON group — a well-known technology company based in Enschede — they bring engineering and production capabilities to the medical device sector. Their H2020 involvement focuses on medical device regulatory compliance, rapid manufacturing adaptation during health crises, and contributing specialized hardware expertise to large research consortia in health and semiconductor domains.

What they specialise in

How they've shifted over time

In the early period (2015–2018), DEMCON Macawi contributed to advanced semiconductor technology (SeNaTe) and began involvement in large-scale clinical research for autism and neurodevelopment (AIMS-2-TRIALS). From 2019 onward, their focus shifted decisively toward medical device regulatory compliance (MDOT) and pandemic-driven manufacturing agility (CO-VERSATILE), reflecting a tighter alignment with their core respiratory device business. The trajectory shows a company moving from broad technology contributions toward strategic focus on medical device compliance and resilient healthcare manufacturing.

Heading toward deeper medical device regulatory expertise and adaptive manufacturing for healthcare emergencies — a strong partner for any consortium dealing with EU MDR compliance or health crisis preparedness.

How they like to work

DEMCON Macawi operates almost exclusively as a third-party contributor or specialist participant rather than a project coordinator (0 coordinated projects out of 4). They join large consortia — evidenced by 148 unique partners across 19 countries — where they contribute specific engineering and manufacturing expertise. This is the profile of a focused industrial partner that delivers technical components within bigger research efforts, not a project initiator.

Despite only 4 projects, they have worked with 148 unique partners across 19 countries — a result of participating in very large consortia like AIMS-2-TRIALS and SeNaTe. Their network is broad but indirect, built through mega-consortia rather than close bilateral partnerships.

What sets them apart

DEMCON Macawi combines respiratory medical device manufacturing expertise with direct experience in EU MDR regulatory processes — a rare combination in H2020 portfolios. Their pandemic response work (CO-VERSATILE) demonstrated the ability to rapidly adapt production lines for urgent medical supply needs, proving operational agility under crisis conditions. For any consortium needing a Dutch industrial partner that understands both the engineering and regulatory sides of medical devices, they are a practical and tested choice.

Highlights from their portfolio

• MDOT
  Their only directly funded project (EUR 735,875), focused on the critical challenge of EU Medical Device Regulation compliance with blockchain-based safety tracking.
• CO-VERSATILE
  Pandemic rapid-response project demonstrating ability to repurpose manufacturing for urgent medical supplies — direct proof of industrial agility.
• AIMS-2-TRIALS
  One of the largest autism research initiatives in Europe (running until 2026), showing long-term commitment to clinical research contributions.